Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LRMR | US
0.10
1.06%
Healthcare
Biotechnology
31/03/2024
26/07/2024
9.52
9.65
9.88
9.34
Larimar Therapeutics Inc. a clinical-stage biotechnology company focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601 which is in Phase 2 clinical trial for the treatment of Friedreich's ataxia a rare progressive and fatal genetic disease. The company is headquartered in Bala Cynwyd Pennsylvania.
View LessPositive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
58.5%1 month
79.7%3 months
87.3%6 months
104.5%-
-
5.43
0.02
0.02
-8.75
-
-
-50.54M
607.40M
607.40M
-
-
-
-
-26.75
4.08
6.92
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.12
Range1M
4.40
Range3M
4.91
Rel. volume
0.37
Price X volume
2.45M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Adeptus Health Inc | ADPT | Biotechnology | 4.51 | 664.63M | 4.16% | n/a | 35.10% |
Sage Therapeutics Inc | SAGE | Biotechnology | 10.99 | 661.40M | 4.97% | n/a | 0.47% |
ANNX | ANNX | Biotechnology | 6.24 | 657.78M | 1.05% | n/a | 11.73% |
ATXS | ATXS | Biotechnology | 11.93 | 655.11M | -0.17% | n/a | 0.05% |
Avid Bioservices Inc | CDMO | Biotechnology | 10.23 | 650.43M | -0.87% | n/a | 0.00% |
GH Research PLC Ordinary Shares | GHRS | Biotechnology | 12.49 | 649.83M | 5.76% | n/a | 0.43% |
Arcturus Therapeutics Ltd | ARCT | Biotechnology | 24.07 | 648.25M | 4.74% | n/a | 12.09% |
Mereo BioPharma Group plc | MREO | Biotechnology | 4.155 | 634.90M | 1.84% | n/a | 14.05% |
KalVista Pharmaceuticals Inc | KALV | Biotechnology | 14.79 | 632.06M | 2.78% | n/a | 3.54% |
Alector Inc | ALEC | Biotechnology | 6.49 | 625.54M | 0.00% | n/a | 20.99% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Ennis Inc | EBF | Building Products & Equipment | 23.82 | 618.94M | 0.76% | 14.34 | 1.15% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.11 | 488.72M | 1.19% | n/a | 138.85% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 30.4 | 487.11M | 1.33% | n/a | 322.60% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 14.3 | 449.64M | 2.36% | 15.90 | 86.68% |
Latham Group Inc. | SWIM | Building Products & Equipment | 3.52 | 406.82M | 7.65% | 77.50 | 80.81% |
Marine Products Corporation | MPX | Recreational Vehicles | 10.66 | 369.72M | 2.01% | 10.15 | 0.00% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 21.09 | 358.13M | 1.93% | 8.78 | 25.57% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 30.42 | 338.35M | 3.65% | 18.42 | -562.47% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 16.94 | 274.56M | 3.55% | 10.83 | 15.44% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 53.41 | 151.69M | -1.22% | 7.97 | 71.47% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -8.75 | -2.85 | Cheaper |
Ent. to Revenue | - | 4,050.30 | - |
PE Ratio | - | 39.84 | - |
Price to Book | 5.43 | 22.96 | Cheaper |
Dividend Yield | - | 1.79 | - |
Std. Deviation (3M) | 87.32 | 75.85 | Par |
Debt to Equity | 0.02 | 0.55 | Cheaper |
Debt to Assets | 0.02 | 0.24 | Cheaper |
Market Cap | 607.40M | 3.61B | Emerging |